Renalytix AI plc


Company Profile

Company website
Health Care Equipment & Services (Medical Equipment)

A developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company uses AI to analyse different sources of information including blood-based biomarkers, genetics and large electronic health record data bases to improve diagnosis and clinical management of kidney disease. The Company is a spin-out of AIM-listed EKF Diagnostics Holdings plc and it's lead product KidneyIntelX™, which is being developed in close collaboration with Mount Sinai and other large US academic medical centres, is due to launch in 2019.


Investor Access Events

Event information
Renalytix AI plc is hosting an investor briefing on AI-enabled diagnostics and kidney disease. To register please email:
Brand Exchange, 3 Birchin Lane, EC3V 9BW
Monday 25 March, 5.15pm for a 5.30pm start